China · Delayed Price · Currency is CNY Aurisco Pharmaceutical Statistics
Total Valuation
SHA:605116 has a market cap or net worth of CNY 8.95 billion. The enterprise value is 9.03 billion.
| Market Cap | 8.95B |
| Enterprise Value | 9.03B |
Important Dates
The last earnings date was Friday, April 17, 2026.
| Earnings Date | Apr 17, 2026 |
| Ex-Dividend Date | Jun 20, 2025 |
Share Statistics
SHA:605116 has 403.41 million shares outstanding. The number of shares has increased by 3.37% in one year.
| Current Share Class | 403.41M |
| Shares Outstanding | 403.41M |
| Shares Change (YoY) | +3.37% |
| Shares Change (QoQ) | -3.58% |
| Owned by Insiders (%) | 74.50% |
| Owned by Institutions (%) | 2.89% |
| Float | 89.55M |
Valuation Ratios
The trailing PE ratio is 23.04 and the forward PE ratio is 16.32.
| PE Ratio | 23.04 |
| Forward PE | 16.32 |
| PS Ratio | 5.31 |
| PB Ratio | 3.29 |
| P/TBV Ratio | 3.50 |
| P/FCF Ratio | 67.67 |
| P/OCF Ratio | 18.49 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.70, with an EV/FCF ratio of 68.25.
| EV / Earnings | 22.93 |
| EV / Sales | 5.36 |
| EV / EBITDA | 14.70 |
| EV / EBIT | 18.85 |
| EV / FCF | 68.25 |
Financial Position
The company has a current ratio of 4.22, with a Debt / Equity ratio of 0.37.
| Current Ratio | 4.22 |
| Quick Ratio | 2.80 |
| Debt / Equity | 0.37 |
| Debt / EBITDA | 1.62 |
| Debt / FCF | 7.51 |
| Interest Coverage | 13.80 |
Financial Efficiency
Return on equity (ROE) is 15.26% and return on invested capital (ROIC) is 15.23%.
| Return on Equity (ROE) | 15.26% |
| Return on Assets (ROA) | 7.35% |
| Return on Invested Capital (ROIC) | 15.23% |
| Return on Capital Employed (ROCE) | 12.69% |
| Weighted Average Cost of Capital (WACC) | 2.64% |
| Revenue Per Employee | 831,562 |
| Profits Per Employee | 194,333 |
| Employee Count | 1,784 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 1.13 |
Taxes
In the past 12 months, SHA:605116 has paid 60.18 million in taxes.
| Income Tax | 60.18M |
| Effective Tax Rate | 13.26% |
Stock Price Statistics
The stock price has increased by +5.92% in the last 52 weeks. The beta is -0.30, so SHA:605116's price volatility has been lower than the market average.
| Beta (5Y) | -0.30 |
| 52-Week Price Change | +5.92% |
| 50-Day Moving Average | 25.94 |
| 200-Day Moving Average | 24.67 |
| Relative Strength Index (RSI) | 30.82 |
| Average Volume (20 Days) | 6,653,799 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:605116 had revenue of CNY 1.68 billion and earned 393.72 million in profits. Earnings per share was 0.96.
| Revenue | 1.68B |
| Gross Profit | 963.86M |
| Operating Income | 479.02M |
| Pretax Income | 453.90M |
| Net Income | 393.72M |
| EBITDA | 607.49M |
| EBIT | 479.02M |
| Earnings Per Share (EPS) | 0.96 |
Balance Sheet
The company has 917.17 million in cash and 993.88 million in debt, with a net cash position of -76.71 million or -0.19 per share.
| Cash & Cash Equivalents | 917.17M |
| Total Debt | 993.88M |
| Net Cash | -76.71M |
| Net Cash Per Share | -0.19 |
| Equity (Book Value) | 2.72B |
| Book Value Per Share | 6.80 |
| Working Capital | 1.55B |
Cash Flow
In the last 12 months, operating cash flow was 484.02 million and capital expenditures -351.74 million, giving a free cash flow of 132.29 million.
| Operating Cash Flow | 484.02M |
| Capital Expenditures | -351.74M |
| Depreciation & Amortization | 128.47M |
| Net Borrowing | -23.34M |
| Free Cash Flow | 132.29M |
| FCF Per Share | 0.33 |
Margins
Gross margin is 57.21%, with operating and profit margins of 28.43% and 23.37%.
| Gross Margin | 57.21% |
| Operating Margin | 28.43% |
| Pretax Margin | 26.94% |
| Profit Margin | 23.37% |
| EBITDA Margin | 36.06% |
| EBIT Margin | 28.43% |
| FCF Margin | 7.85% |
Dividends & Yields
This stock pays an annual dividend of 0.34, which amounts to a dividend yield of 1.50%.
| Dividend Per Share | 0.34 |
| Dividend Yield | 1.50% |
| Dividend Growth (YoY) | 31.82% |
| Years of Dividend Growth | 5 |
| Payout Ratio | 31.50% |
| Buyback Yield | -3.37% |
| Shareholder Yield | -1.88% |
| Earnings Yield | 4.40% |
| FCF Yield | 1.48% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |